Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic networks in mutant KRAS-driven tumours: tissue specificities and the microenvironment
Samuel A. Kerk, Thales Papagiannakopoulos, Yatrik M. Shah, et al.
Nature reviews. Cancer (2021) Vol. 21, Iss. 8, pp. 510-525
Open Access | Times Cited: 153

Showing 26-50 of 153 citing articles:

PDAC, the Influencer Cancer: Cross-Talk with Tumor Microenvironment and Connected Potential Therapy Strategies
Leonardo Mercanti, Maria Sindaco, Mariangela Mazzone, et al.
Cancers (2023) Vol. 15, Iss. 11, pp. 2923-2923
Open Access | Times Cited: 21
The Therapeutic Landscape for KRAS-Mutated Colorectal Cancers
Simon Manuel Tria, Matthew Burge, Vicki Whitehall
Cancers (2023) Vol. 15, Iss. 8, pp. 2375-2375
Open Access | Times Cited: 20
Combined inhibition of pyruvate dehydrogenase kinase 1 and lactate dehydrogenase a induces metabolic and signaling reprogramming and enhances lung adenocarcinoma cell killing
Yan Zhou, Yizhen Guo, Maoxin Ran, et al.
Cancer Letters (2023) Vol. 577, pp. 216425-216425
Closed Access | Times Cited: 20
Therapeutic strategies targeting AMPK-dependent autophagy in cancer cells
Wenbin Yuan, Wanyi Fang, Rui Zhang, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2023) Vol. 1870, Iss. 7, pp. 119537-119537
Closed Access | Times Cited: 19
AKT1 phosphorylation of cytoplasmic ME2 induces a metabolic switch to glycolysis for tumorigenesis
Taiqi Chen, Siyi Xie, Jie Cheng, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Emerging mechanisms and promising approaches in pancreatic cancer metabolism
Hao Wu, Mengdi Fu, Mengwei Wu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 8
Open Access | Times Cited: 7
AMPK: The Energy Sensor at the Crossroads of Aging and Cancer
Vasudevarao Penugurti, Rajesh Manne, Ling Bai, et al.
Seminars in Cancer Biology (2024) Vol. 106-107, pp. 15-27
Closed Access | Times Cited: 7
From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies
Ehsan Gharib, Gilles A. Robichaud
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9463-9463
Open Access | Times Cited: 7
Cross‐Talk between Oxidative Stress and m6A RNA Methylation in Cancer
Baishuang Yang, Qiong Chen
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 38
The Crosstalk Between Signaling Pathways and Cancer Metabolism in Colorectal Cancer
Kha Wai Hon, Syafiq Asnawi Zainal Abidin, Iekhsan Othman, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 37
Targeting KRAS in Lung Cancer Beyond KRAS G12C Inhibitors: The Immune Regulatory Role of KRAS and Novel Therapeutic Strategies
Marc Cucurull, L. Notario, Montse Sánchez‐Céspedes, et al.
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 26
Immunological control of ovarian carcinoma by chemotherapy and targeted anticancer agents
Jitka Fučíková, Lenka Palová-Jelínková, Vanessa Klapp, et al.
Trends in cancer (2022) Vol. 8, Iss. 5, pp. 426-444
Open Access | Times Cited: 26
Dual Inhibitions on Glucose/Glutamine Metabolisms for Nontoxic Pancreatic Cancer Therapy
Yingying Xu, Zhiguo Yu, Hao Fu, et al.
ACS Applied Materials & Interfaces (2022) Vol. 14, Iss. 19, pp. 21836-21847
Closed Access | Times Cited: 26
The interactive role of inflammatory mediators and metabolic reprogramming in pancreatic cancer
Yuuki Ohara, Paloma Valenzuela, S. Perwez Hussain
Trends in cancer (2022) Vol. 8, Iss. 7, pp. 556-569
Open Access | Times Cited: 26
NetrinG1+ Cancer-Associated Fibroblasts Generate Unique Extracellular Vesicles that Support the Survival of Pancreatic Cancer Cells Under Nutritional Stress
Kristopher S. Raghavan, Ralph Francescone, Janusz Franco‐Barraza, et al.
Cancer Research Communications (2022) Vol. 2, Iss. 9, pp. 1017-1036
Open Access | Times Cited: 26
Interplays of glucose metabolism and KRAS mutation in pancreatic ductal adenocarcinoma
Yu-Huei Liu, Chun‐Mei Hu, Yuan-Sheng Hsu, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 9
Open Access | Times Cited: 26
Efficient Correction of Oncogenic KRAS and TP53 Mutations through CRISPR Base Editing
Shady Sayed, Olga Alexandra Sidorova, Alexander Hennig, et al.
Cancer Research (2022) Vol. 82, Iss. 17, pp. 3002-3015
Open Access | Times Cited: 24
The Role of Tumor Metabolic Reprogramming in Tumor Immunity
Xianhong Zhang, Weiguo Song, Yue Gao, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17422-17422
Open Access | Times Cited: 15
Serine Metabolic Reprogramming in Tumorigenesis, Tumor Immunity, and Clinical Treatment
Shunxi Wang, Yuan Xiaoxue, Song Guanbin, et al.
Advances in Nutrition (2023) Vol. 14, Iss. 5, pp. 1050-1066
Open Access | Times Cited: 14
NF2: An underestimated player in cancer metabolic reprogramming and tumor immunity
Duo Xu, Shiyuan Yin, Yongqian Shu
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 4
Mimicking and analyzing the tumor microenvironment
Roxane Crouigneau, Yanfang Li, Jamie Auxillos, et al.
Cell Reports Methods (2024) Vol. 4, Iss. 10, pp. 100866-100866
Open Access | Times Cited: 4
KIRSTEN RAT SARCOMA VIRUS MUTATIONS EFFECT ON TUMOR DOUBLING TIME AND PROGNOSIS OF SOLID DOMINANT STAGE I LUNG ADENOCARCINOMA
Riccardo Tajè, Vincenzo Ambrogi, Federico Tacconi, et al.
Clinical Lung Cancer (2025)
Closed Access
Distinct molecular and clinical features of specific variants of KRAS codon 12 in pancreatic adenocarcinoma
Bach Ardalan, Aaron Ciner, Yasmine Baca, et al.
Clinical Cancer Research (2025)
Open Access
Biosynthetic plasticity enables CD8+ T cell functional resilience under nutrient stress
Michael Scaglione, Montana Knight, Krittin Trihemasava, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
KRASG12D-driven pentose phosphate pathway remodeling imparts a targetable vulnerability synergizing with MRTX1133 for durable remissions in PDAC
Xiangyan Jiang, Tao Wang, Bin Zhao, et al.
Cell Reports Medicine (2025) Vol. 6, Iss. 2, pp. 101966-101966
Open Access

Scroll to top